Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by George Wilding
Docetaxel and Dasatinib or Placebo in Men With Metastatic Castration-Resistant Prostate Cancer (READY): A Randomised, Double-Blind Phase 3 Trial
The Lancet Oncology
Oncology
Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial
The Lancet
Medicine
A Phase I Study of AT-101 With Cisplatin and Etoposide in Patients With Advanced Solid Tumors With an Expanded Cohort in Extensive-Stage Small Cell Lung Cancer
Investigational New Drugs
Oncology
Pharmacology
A Phase I Trial of MK-0731, a Kinesin Spindle Protein (KSP) Inhibitor, in Patients With Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Expression of Spermidine/Spermine N1-Acetyl Transferase (SSAT) in Human Prostate Tissues Is Related to Prostate Cancer Progression and Metastasis
Prostate
Oncology
Urology
Targeting Androgen Receptor and JunD Interaction for Prevention of Prostate Cancer Progression
Prostate
Oncology
Urology
Vorinostat in Combination With Bortezomib in Patients With Advanced Malignancies Directly Alters Transcription of Target Genes
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Population Pharmacokinetics of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (Triapine®) in Cancer Patients
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Eastern Cooperative Oncology Group Phase II Trial of Lapatinib in Men With Biochemically Relapsed, Androgen Dependent Prostate Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy
Clinical Genitourinary Cancer
Oncology
Urology
1
2
›
